Allan D. Kirk received his MD and PhD in Immunology from Duke University, where he also completed his surgery residency. He completed a multi-organ transplant fellowship at the University of Wisconsin, during which time he began his longstanding work on costimulation blockade and personalized immune management. He advanced this work as Chief of Transplant Research for the Armed Services Transplant Service in Washington, DC, and subsequently as Chief of the intramural organ transplant program at the National Institutes of Health. In 2007, he moved to Emory University, as Vice Chair for Surgical Research, and in 2014, was appointed Chair of the Department of Surgery at Duke University. Dr. Kirk is the David C. Sabiston, Jr. Distinguished Professor and holds Professorships in Surgery, Pediatrics and Immunology. He also serves as Surgeon-in-Chief for the Duke University Health System. In addition to his clinical transplant practice, he has published over 350 scientific manuscripts, and continues NIH-, DoD- and FDA-sponsored investigations in organ transplantation and immune management. He has focused increasingly on the curation and analysis of multidimensional data for use in Real World Evidence trial design, clinical decision support tool development and drug discovery. He was named an Academy of Master Surgeon Educators by the American College of Surgeons in 2019, and served as the Editor-in-Chief of the American Journal of Transplantation from 2010 to 2020. Dr. Kirk is also an elected member of the National Academy of Medicine.
15:00 - 15:45
|Industry Symposium — A new era in islet transplants: xeno, stem cells, and beyond
eGenesis Sponsored Symposium